{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-054876","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.264947+00:00","generated_at":"2026-05-20T04:12:49.217206+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ReShape Lifesciences enters $9.7M at-the-market equity distribution agreement with Maxim Group","bullets":["Agreement allows sale of up to $9.7M of common stock via ATM offering; effective May 30, 2025.","Maxim receives 3.0% commission on gross proceeds plus up to $50K legal fee reimbursement and $3K per due diligence session.","Shares sold under existing effective S-3 shelf registration (File No. 333-287168).","Company has no obligation to sell; offering ends upon sale of $9.7M or termination by either party."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-054876","json":"https://secwatch.observer/filing/0001104659-25-054876.json","markdown":"https://secwatch.observer/filing/0001104659-25-054876.md","text":"https://secwatch.observer/filing/0001104659-25-054876.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000110465925054876/0001104659-25-054876-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000110465925054876/tm2516583d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:12:49.217206+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}